Suven Life Scie.

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE495B01038
NSEID: SUVEN
BSEID: 530239
View on NSE | View on BSE

INR

268.85

-0.15 (-0.06%)

BSENSE

May 20

BSE+NSE Vol: 32.31 lacs

{
  "main_header": {
    "sid": 588414,
    "name": "Suven Life Scie.",
    "stock_name": "Suven Life Scie.",
    "full_name": "Suven Life Sciences Ltd",
    "name_url": "stocks-analysis/suven-life-scie",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "268.85",
    "chg": -0.15,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "269.00",
    "mcapval": "7,210.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530239,
    "symbol": "SUVEN",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE495B01038",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "32.31 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/suven-life-scie-588414-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Suven Life Sciences Ltd Surges 7.64% to Day's High of Rs 269.65 — Outperforms Sector by 5.49 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-hits-intraday-high-with-764-surge-on-19-may-2026-3998588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SuvenLifeScienc_priceRelatedfactors_3998588.png",
        "date": "2026-05-19 09:46:16",
        "description": "The Sensex rose 0.49% on 19 May 2026, yet Suven Life Sciences Ltd outpaced the broader market with a robust 7.64% gain, outperforming its Healthcare Services sector by 5.49 percentage points. This sharp single-session advance marks the third consecutive day of gains, extending a recent rally that has delivered nearly 30% returns over this brief period."
      },
      {
        "title": "Suven Life Sciences Ltd Upgraded to Sell by MarketsMOJO on Improving Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suven-life-sciences-ltd-upgraded-to-sell-by-marketsmojo-on-improving-financial-and-technical-trends-3998360",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SuvenLifeScienc_mojoScore_3998360.png",
        "date": "2026-05-19 08:46:11",
        "description": "Suven Life Sciences Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a notable improvement in its financial and technical parameters despite ongoing challenges. The healthcare services company’s recent quarterly results and market performance have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, signalling cautious optimism among investors."
      },
      {
        "title": "Suven Life Sciences Ltd Shows Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-shows-technical-momentum-shift-amid-strong-price-rally-3997979",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SuvenLifeScienc_technicaldot_3997979.png",
        "date": "2026-05-19 08:03:34",
        "description": "Suven Life Sciences Ltd has experienced a notable shift in price momentum, reflected in a 19.83% surge in a single day, signalling a transition from a mildly bearish to a mildly bullish technical trend. Despite a modest downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s recent performance and technical indicators present a nuanced picture for investors navigating the healthcare services sector."
      },
      {
        "title": "Suven Life Sciences Ltd Surges 11.72% to Day's High of Rs 235.55 — Outperforms Sector by 12.23 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-hits-intraday-high-with-1172-surge-on-18-may-2026-3996743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SuvenLifeScienc_priceRelatedfactors_3996743.png",
        "date": "2026-05-18 10:15:57",
        "description": "In a session marked by broad market weakness, Suven Life Sciences Ltd defied the trend with an impressive 11.72% gain on 18 May 2026, reaching an intraday high of Rs 235.55. This outperformance by 12.23 percentage points over its Healthcare Services sector peers highlights a distinctly stock-specific rally amid a declining Sensex."
      },
      {
        "title": "Suven Life Sciences Falls 5.76%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-falls-576-3-key-factors-driving-the-weekly-decline-3994735",
        "imagepath": "",
        "date": "2026-05-16 17:01:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Stock opens at Rs.224.15, begins week with sharp decline</p>\n                    <p><strong>12 May:</strong> Mixed technical signals emerge amid mildly bearish momentum</p>\n                    <p><strong>13 May:</strong> Q4 FY26 results reveal mounting losses</p>\n                    <p><strong>14 May:</strong> Financial trend improves but quarterly performance remains flat</p>\n                    <p><strong>15 May:</strong> Stock recovers slightly, closing at Rs.211.25</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.224.15</div></div>\n  ..."
      },
      {
        "title": "Are Suven Life Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-suven-life-sciences-ltd-latest-results-good-or-bad-3991729",
        "imagepath": "",
        "date": "2026-05-14 19:19:56",
        "description": "Suven Life Sciences Ltd's latest financial results for Q4 FY26 reveal significant operational challenges. The company reported net sales of ₹1.52 crores, which represents a quarter-on-quarter decline of 45.91% from ₹2.81 crores in Q3 FY26. This sharp drop in revenue underscores a troubling trend, as the company has struggled to maintain sales momentum. \n\nThe net loss for the quarter stood at ₹45.60 crores, reflecting a substantial increase in losses compared to the previous quarter, where the loss was ₹101.92 crores. This indicates a deterioration in the company's financial health, with the operating margin plummeting to a staggering negative 3,331.58%. Such a figure highlights severe inefficiencies within the company's cost structure, particularly as employee costs significantly exceed revenue.\n\nDespite some marginal year-on-year improvement in revenue from ₹1.47 crores in Q4 FY25, the overall financial pe..."
      },
      {
        "title": "Suven Life Sciences Ltd Reports Flat Quarterly Performance Amid Improving Financial Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-reports-flat-quarterly-performance-amid-improving-financial-trend-3990262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SuvenLifeScienc_fintrenddot_3990262.png",
        "date": "2026-05-14 08:00:08",
        "description": "Suven Life Sciences Ltd has reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from the negative trend observed in the previous quarter. Despite the lack of significant revenue growth, the company’s earnings per share (EPS) reached its highest quarterly level at Rs -1.73, signalling a stabilisation in operational margins and a potential turning point for the small-cap healthcare services firm."
      },
      {
        "title": "Suven Life Sciences Q4 FY26: Mounting Losses Signal Deepening Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/suven-life-sciences-q4-fy26-mounting-losses-signal-deepening-crisis-3990027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SuvenLifeScienc_quaterlyResult_3990027.png",
        "date": "2026-05-13 19:31:54",
        "description": "Suven Life Sciences Ltd., a Hyderabad-based healthcare services company, reported a net loss of ₹45.60 crores for Q4 FY26, marking a deterioration of 55.26% quarter-on-quarter and 3.78% year-on-year. With a market capitalisation of ₹5,685 crores and trading at ₹209.80 following a 2.53% decline post-results, the stock reflects investor concerns about the company's persistent inability to achieve profitability despite minimal revenue generation."
      },
      {
        "title": "Suven Life Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suven-life-sciences-ltd-is-rated-strong-sell-3987373",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SuvenLifeScienc_mojoScore_3987373.png",
        "date": "2026-05-12 10:10:25",
        "description": "Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Aug 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 12 May 2026, providing investors with the latest comprehensive view of the company’s position."
      }
    ],
    "total": 5289,
    "sid": "588414",
    "stock_news_url": "https://www.marketsmojo.com/news/suven-life-sciences-588414"
  },
  "announcements": [
    {
      "caption": "Clarification On Volume Movement Letter",
      "datetime": "19-May-2026",
      "details": "Clarification on Volume Movement Letter",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Suven Life Sciences Ltd",
      "datetime": "19-May-2026",
      "details": "The Exchange has sought clarification from Suven Life Sciences Ltd on May 19 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-May-2026",
      "details": "Newspaper Publication - Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has declared <strong>150%</strong> dividend, ex-date: 14 Feb 19",
          "dt": "2019-02-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:2</strong> stock split, ex-date: 23 Mar 07",
          "dt": "2007-03-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Mar 07",
          "dt": "2007-03-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:2</strong> rights issue, ex-date: 17 Oct 22",
          "dt": "2022-10-17",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Suven Life Sciences Ltd Surges 7.64% to Day's High of Rs 269.65 — Outperforms Sector by 5.49 Percentage Points

2026-05-19 09:46:16

The Sensex rose 0.49% on 19 May 2026, yet Suven Life Sciences Ltd outpaced the broader market with a robust 7.64% gain, outperforming its Healthcare Services sector by 5.49 percentage points. This sharp single-session advance marks the third consecutive day of gains, extending a recent rally that has delivered nearly 30% returns over this brief period.

Read full news article

Suven Life Sciences Ltd Upgraded to Sell by MarketsMOJO on Improving Financial and Technical Trends

2026-05-19 08:46:11

Suven Life Sciences Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a notable improvement in its financial and technical parameters despite ongoing challenges. The healthcare services company’s recent quarterly results and market performance have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, signalling cautious optimism among investors.

Read full news article

Suven Life Sciences Ltd Shows Technical Momentum Shift Amid Strong Price Rally

2026-05-19 08:03:34

Suven Life Sciences Ltd has experienced a notable shift in price momentum, reflected in a 19.83% surge in a single day, signalling a transition from a mildly bearish to a mildly bullish technical trend. Despite a modest downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s recent performance and technical indicators present a nuanced picture for investors navigating the healthcare services sector.

Read full news article

Suven Life Sciences Ltd Surges 11.72% to Day's High of Rs 235.55 — Outperforms Sector by 12.23 Percentage Points

2026-05-18 10:15:57

In a session marked by broad market weakness, Suven Life Sciences Ltd defied the trend with an impressive 11.72% gain on 18 May 2026, reaching an intraday high of Rs 235.55. This outperformance by 12.23 percentage points over its Healthcare Services sector peers highlights a distinctly stock-specific rally amid a declining Sensex.

Read full news article

Suven Life Sciences Falls 5.76%: 3 Key Factors Driving the Weekly Decline

2026-05-16 17:01:05

Key Events This Week

11 May: Stock opens at Rs.224.15, begins week with sharp decline

12 May: Mixed technical signals emerge amid mildly bearish momentum

13 May: Q4 FY26 results reveal mounting losses

14 May: Financial trend improves but quarterly performance remains flat

15 May: Stock recovers slightly, closing at Rs.211.25

Week Open

Rs.224.15

...

Read full news article

Are Suven Life Sciences Ltd latest results good or bad?

2026-05-14 19:19:56

Suven Life Sciences Ltd's latest financial results for Q4 FY26 reveal significant operational challenges. The company reported net sales of ₹1.52 crores, which represents a quarter-on-quarter decline of 45.91% from ₹2.81 crores in Q3 FY26. This sharp drop in revenue underscores a troubling trend, as the company has struggled to maintain sales momentum. The net loss for the quarter stood at ₹45.60 crores, reflecting a substantial increase in losses compared to the previous quarter, where the loss was ₹101.92 crores. This indicates a deterioration in the company's financial health, with the operating margin plummeting to a staggering negative 3,331.58%. Such a figure highlights severe inefficiencies within the company's cost structure, particularly as employee costs significantly exceed revenue. Despite some marginal year-on-year improvement in revenue from ₹1.47 crores in Q4 FY25, the overall financial pe...

Read full news article

Suven Life Sciences Ltd Reports Flat Quarterly Performance Amid Improving Financial Trend

2026-05-14 08:00:08

Suven Life Sciences Ltd has reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from the negative trend observed in the previous quarter. Despite the lack of significant revenue growth, the company’s earnings per share (EPS) reached its highest quarterly level at Rs -1.73, signalling a stabilisation in operational margins and a potential turning point for the small-cap healthcare services firm.

Read full news article

Suven Life Sciences Q4 FY26: Mounting Losses Signal Deepening Crisis

2026-05-13 19:31:54

Suven Life Sciences Ltd., a Hyderabad-based healthcare services company, reported a net loss of ₹45.60 crores for Q4 FY26, marking a deterioration of 55.26% quarter-on-quarter and 3.78% year-on-year. With a market capitalisation of ₹5,685 crores and trading at ₹209.80 following a 2.53% decline post-results, the stock reflects investor concerns about the company's persistent inability to achieve profitability despite minimal revenue generation.

Read full news article

Suven Life Sciences Ltd is Rated Strong Sell

2026-05-12 10:10:25

Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Aug 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 12 May 2026, providing investors with the latest comprehensive view of the company’s position.